References
- Apolone G, Cattaneo A, Colombo P, La Vecchia C, Cavazzuti L, Bamfi F. Knowledge and opinion on prostate and prevalence of self-reported BPH and prostate-related events. A cross-sectional survey in Italy. Eur J Cancer Prey 11 (5) : 473-479, 2002 https://doi.org/10.1097/00008469-200210000-00010
- Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 150 (1) : 85-89, 1993
- Norman RW, Nickel JC, Fish D, Pickett SN. 'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms. Br J UroI 74 (5) : 542-550, 1994 https://doi.org/10.1111/j.1464-410X.1994.tb09181.x
- Tsukamoto T, Kumamoto Y, Masumori N, Miyake H, Rhodes T, Girman CJ, Guess HA, Jacobsen SJ, Lieber MM. Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 154 (2 Pt 1) : 391-395, 1995
- Hunter DJ, Berra-Unamuno A, Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J Urol 155 (6): 1965-1970, 1996 https://doi.org/10.1016/S0022-5347(01)66063-4
- Engstrom G, Walker-Engstrom ML, Loof L, Leppert J. Prevalence of three lower urinary tract symptoms in men-a population-based study. Fam Pract 20 (1) : 7-10, 2003 https://doi.org/10.1093/fampra/20.1.7
- Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet. 1991 Aug 24; 338 (8765) : 469-471. Gass R. Benign prostate hyperplasia: the opposite effects of alcohol and coffee intake. BJU International 90: 649-654, 2002 https://doi.org/10.1046/j.1464-410X.2002.03001.x
- Bosch JL, Hop WC, Kirkels WJ, Schroder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 75 (5) : 622-630, 1995 https://doi.org/10.1111/j.1464-410X.1995.tb07421.x
- Chicharro-Molero JA, Burgos-Rodriguez R, Sanchez-Cruz JJ, del Rosal-Samaniego JM, Rodero-Carcia P, Rodriguez-Vallejo JM. Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older. J Urol 159 (3) : 878-882, 1998 https://doi.org/10.1016/S0022-5347(01)63760-1
- Blanker MH, Groeneveld FP, Prins A, Bernsen RM, Bohnen AM, Bosch JL. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital trat problens and general health status. BJU Int 85 (6) : 665-671, 2000 https://doi.org/10.1046/j.1464-410x.2000.00570.x
- Choi J, Ikeguchi EF, Lee SW, Choi HY, Te AE, Kaplan SA. Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index? Eur Urol 42 (1) : 7-11, 2002 https://doi.org/10.1016/S0302-2838(02)00222-1
- Lee ES, Lee C, Kim Y, Shin Y. Estimation of benign prostatic hyperplasia prevalence in Korea: An epidemiological survey using International Prostatic Symptom Score (IPSS) in Yonchon county. Korean J Urol 36 (12) : 1345-1352, 1995
- Cho BM, Lee SD, Chung MK. The lifestyle factors in relation to benign prostatic hyperplasia in a rural community. Korean J Urol 40 (5) : 589-593, 1999
- Cho KS. Prevalemce of lower urinary tract symptoms (LUTS) in Korean elderly men: Epidemiologic survey using International Prostatic Symptom Score (I-PSS). Graduate School of Seoul University, Thesis of Master of Science, 2000
- Cho KS, Jo MK, Lim D, Son H, Park SK, Yoo KY, Kim HH, Lee C. Epidemiologic survey using International Prostate Symptom Score (I-PSS) of lowe urinary tract symptoms (LUTS) in elderly men above 40 years old in Seoul area. Korean J Urol 42 (8) : 840-848, 2001
- Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 17: 461-475, 1990
- Tan MO, Karabiyik I, Uygur MC, Diker Y, Erol D. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia. Int Urol Nephrol 35 (3) : 357-363, 2003 https://doi.org/10.1023/B:UROL.0000022909.57112.3e
- Boyle P, McGinn R, Maisonneuve P, La Vecchia C. Epidemiology of benign prostatic hyperplasia: Present knowledge and studies needed. Eur Urol 20 (I SuppI): 3-10, 1991
- Lee E, Park M-S, Shin C, Lee H, Yoo K, Kim Y, Shin Y, Paik H-Y, Lee C. A high-risk group for prostatism: a population-based epidemiological study in Korea. Br J Urol 79: 736-741, 1997 https://doi.org/10.1046/j.1464-410X.1997.00149.x
- Platz EA, Rimm EB, Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Ginovannucci E. Alcohol consumption, cigarette smoking, and risk of benign prostate hyperplasia. Am J Epidemiol 149: 106-115, 1999 https://doi.org/10.1093/oxfordjournals.aje.a009775
- Koskimaki J, Hakama M, Huhtala H, Tammela TLJ. Association of dietary elements and lower urinary tract symptoms. Scand J Urol Nephrol 34: 46-50, 2000 https://doi.org/10.1080/003655900750016887
- Meigs JB, Mojr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54: 935-944, 2001 https://doi.org/10.1016/S0895-4356(01)00351-1
- Suzuki S, Platz EA, Kawachi I, Willett WC, Giovanntcci E. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 75: 689-697, 2002
- Gass R. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake. BJU Int 90 (7) : 649-654, 2002 https://doi.org/10.1046/j.1464-410X.2002.03001.x
- Dahle SE, Chokkalingam AP, Gao Y-T, Deng J, Stanczyk FZ, Hsing AW. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. The Journal of Urology 168: 599-604, 2002 https://doi.org/10.1016/S0022-5347(05)64687-3
- Joseph MA, Harlow SD, Wei JT, Sarma AV, Dunn RL, Taylor JMG, James SA, Cooney KA, Doerr KM, Montie JE, Schottenfeld D. Risk factors for lower urinary tract symptoms in a population-based sample of African-American Men. Am J Epidemiol 157: 906-914. 2003 https://doi.org/10.1093/aje/kwg051
- Kliewer EV. Benign prostatic hyperplasia morbidity and mortality among immigrants in Australia and Canada. Prostate 28: 211-218, 1996 https://doi.org/10.1002/(SICI)1097-0045(199604)28:4<211::AID-PROS1>3.0.CO;2-G
- Lagiou P, Wuu J, Trichopoulou A, Hsieh CC, Adami HO, Trichopoulos D. Diet and benign prostatic hyperplasia: A study in Greece. Urology 54: 284-290, 1999 https://doi.org/10.1016/S0090-4295(99)00096-5
- Koskimaki J, Hakama M, Huhtala H, Tammela TLJ. Association of dietary elements and lower urinary tract symptoms. Scand J Urol Nephrol 34: 46-50, 2000 https://doi.org/10.1080/003655900750016887
- Ning X, Shi JP, Wu ZY, Zheng LG, Wang HL. A case-control study on the risk factors of benign prostate hyperplasia in th suburb of Shenyang. Zhonghua Liu Xing Bing Xue Za Zhi 24: 276-80, 2003
- The Korean Nutrition Society. Can-Pro version 2.0, 2003
- Kim H-G, Park JY, lung SM, Lee SH, Lee SY. Benign prostatic hyperplasia: Its feature and impact on the quality of life in rural area of Kangwon province. Koean J Urol 40 (4) : 446-452, 1999
- Chyou PH, Nomura AMY, Stemmermann GN, Hankin JH. A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate 22: 253-264, 1993 https://doi.org/10.1002/pros.2990220308
- Araki H, Watanabe H, Mishina T, Nakao M. High-risk group for benign prostatic hypertrophy. Prostate 4: 253-264, 1983 https://doi.org/10.1002/pros.2990040305
- Fitzpatrick JM, Lynch TH. Phytotherapeutic agents. In: Kirby R, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P, editors. Textbook of benign prostatic hyperplasia. Oxford: ISIS Medical Media, pp.331-337, 1996
- Glick M, Michel AC, Dorn J, Horwitz M, Rosenthal T, Trevisan M. Dietary cardiovascular risk factors and serum cholesterol in an Old Order Mennonite community. Am J Public Health 88: 1202-1205, 1998 https://doi.org/10.2105/AJPH.88.8.1202
- Gu F. Changes in the prevalence of benign prostatic hyperplasia in China. Chin Med J (Engl) 110 (3) : 163-166, 1997
- Graves EJ, Gillium BS. Detailed diagnoses and procedures. National Hospital Disease Survey, 1994. Vital Health Stat 13 130: 1-146, 1997
- Fitzpatrick JM, Lynch TH. Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia. Urol Clin N Am 22: 407-412, 1995
- Wiza A, Lisette G, Ybel B, Reggy W. Assessing diets of elderly people: problem and approaches. Am J Clin Nutr 59 (suppI) : 221-223, 1994